Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy

With the success of immune checkpoint inhibitors (ICIs), significant progress has been made in the field of cancer immunotherapy. Despite the long-lasting outcomes in responders, the majority of patients with cancer still do not benefit from this revolutionary therapy. Increasing evidence suggests t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Exp Clin Cancer Res
Autori principali: Wang, Bin, Zhao, Qin, Zhang, Yuyu, Liu, Zijing, Zheng, Zhuangzhuang, Liu, Shiyu, Meng, Lingbin, Xin, Ying, Jiang, Xin
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7796640/
https://ncbi.nlm.nih.gov/pubmed/33422072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01820-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi